7.29
비구획 분석: 기타 약동학적 매개변수
비구획 접근법은 약물의 신체 행동을 평가하기 위해 약동학에서 널리 사용되는 방법입니다. 청소율, 생체이용률, 총 분포 용적을 포함한 여러 요소를 고려합니다.
비구획 접근법의 한 가지 핵심 측면은 약물의 총 청소율을 결정하는 것입니다. 이는 약물 복용량을 0에서 무한대까…
비구획 접근법은 청소율, 생체이용률 및 총 분포량을 포함한 다양한 요인을 활용합니다.
일단 약물이 투여되면, 약물의 총 제거량은 약물 투여량을 사다리꼴 방법으로 얻은 0에서 무한대까지의 농도-시간 곡선 아래 면적으로 나누어 결정할 수 있습니다.
생체이용률 F는 약물의 경구 및 정맥 투여 후 약물 농도 데이터를 사용하여 결정할 수 있습니다.
총 분포량 Vss는 클리어런스와 평균 체류 시간의 곱입니다.
평균 체류 시간은 정맥 주사를 한 번 투여한 후에만 쉽게 계산할 수 있으며, 이는 구획 접근법에 비해 비구획 접근법의 한계입니다.
View the full transcript and gain access to JoVE Core videos
Q1: How is total drug clearance calculated in noncompartmental analysis?
Total drug clearance is calculated by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall exposure in the body over time and is commonly determined using the trapezoidal method, a numerical integration technique that estimates this critical pharmacokinetic parameter.
Q2: What does bioavailability measure in drug administration?
Bioavailability, denoted as F, refers to the fraction of an administered dose that reaches the systemic circulation unchanged. It is determined by analyzing drug concentration data after both oral and intravenous administration, providing insights into how much of the drug is actually absorbed and available for therapeutic effect in the body.
Q3: How is the total volume of distribution calculated?
The total volume of distribution, represented as Vss, is calculated by multiplying the drug's clearance by the mean residence time. Mean residence time refers to the average time a drug molecule spends in the body, making this calculation essential for understanding how extensively a drug distributes throughout body tissues and fluids.
Q4: What is a key limitation of the noncompartmental approach?
The noncompartmental approach has a significant limitation in calculating mean residence time, which can only be readily determined after a single intravenous dose. This restriction distinguishes the noncompartmental approach from the compartmental approach, which allows greater flexibility in estimating pharmacokinetic parameters under various dosing scenarios.
Q5: Why is the trapezoidal method used in noncompartmental analysis?
The trapezoidal method is a numerical integration technique commonly employed to calculate the area under the concentration-time curve from zero to infinity. This method provides an accurate estimate of total drug exposure over time, which is essential for determining clearance and other critical pharmacokinetic parameters in the noncompartmental approach.
Q6: What factors does the noncompartmental approach consider when assessing drug behavior?
The noncompartmental approach utilizes three primary factors: clearance, bioavailability, and total volume of distribution. These parameters collectively assess how drugs are absorbed, distributed, and eliminated from the body, providing a comprehensive model-independent evaluation of drug behavior without requiring assumptions about specific compartmental structures.
Q7: How does the noncompartmental approach differ from the compartmental approach?
The noncompartmental approach is model-independent and does not assume specific body compartments, making it more flexible for various dosing scenarios. However, it cannot readily calculate mean residence time except after single intravenous doses, whereas the compartmental approach allows more flexibility in parameter estimation but requires assumptions about drug distribution into defined body compartments.